Subcutaneous apomorphine for neuroleptic malignant syndrome.
Lattanzi
Lorenzo
L
Mungai
Francesco
F
Romano
Anna
A
Bonuccelli
Ubaldo
U
Cassano
Giovanni B
GB
Fagiolini
Andrea
A
D001058:Apomorphine / Q000008:administration & dosage* / Q000627:therapeutic use; D018491:Dopamine Agonists / Q000008:administration & dosage* / Q000627:therapeutic use; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D007279:Injections, Subcutaneous; D008875:Middle Aged; D009459:Neuroleptic Malignant Syndrome / Q000188:drug therapy*; D016896:Treatment Outcome
D018491:Dopamine Agonists; D001058:Apomorphine